Hydrogen/Deuterium Exchange Mass Spectrometry Reveals Specific Changes in the Local Flexibility of Plasminogen Activator Inhibitor 1 upon Binding to the Somatomedin B Domain of Vitronectin

被引:27
作者
Trelle, Morten Beck [1 ]
Hirschberg, Daniel [1 ]
Jansson, Anna [1 ]
Ploug, Michael [2 ,3 ]
Roepstorff, Peter [1 ]
Andreasen, Peter A. [4 ]
Jorgensen, Thomas J. D. [1 ]
机构
[1] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark
[2] Rigshosp, Finsen Lab, DK-2200 Copenhagen N, Denmark
[3] Copenhagen Bioctr, BRIC, DK-2200 Copenhagen, Denmark
[4] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark
关键词
REACTIVE-CENTER LOOP; NEUROSERPIN INCLUSION-BODIES; FLEXIBLE-JOINT REGION; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; FAMILIAL ENCEPHALOPATHY; METASTABLE SERPIN; SHUTTER REGION; FORMS POLYMERS; TYPE-1;
D O I
10.1021/bi3008998
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The native fold of plasminogen activator inhibitor 1 (PAI-1) represents an active metastable conformation that spontaneously converts to an inactive latent form. Binding of the somatomedin B domain (SMB) of the endogenous cofactor vitronectin to PAI-1 delays the transition to the latent state and increases the thermal stability of the protein dramatically. We have used hydrogen/deuterium exchange mass spectrometry to assess the inherent structural flexibility of PAI-1 and to monitor the changes induced by SMB binding. Our data show that the PAI-1 core consisting of beta-sheet B is rather protected against exchange with the solvent, while the remainder of the molecule is more dynamic. SMB binding causes a pronounced and widespread stabilization of PAI-1 that is not confined to the binding interface with SMB. We further explored the local structural flexibility in a mutationally stabilized PAI-1 variant (14-1B) as well as the effect of stabilizing antibody Mab-1 on wild-type PAI-1. The three modes of stabilizing PAI-1 (SMB, Mab-1, and the mutations in 14-1B) all cause a delayed latency transition, and this effect was accompanied by unique signatures on the flexibility of PAI-1. Reduced flexibility in the region around helices B, C, and I was seen in all three cases, which suggests an involvement of this region in mediating structural flexibility necessary for the latency transition. These data therefore add considerable depth to our current understanding of the local structural flexibility in PAI-1 and provide novel indications of regions that may affect the functional stability of PAI-1.
引用
收藏
页码:8256 / 8266
页数:11
相关论文
共 47 条
[1]   Antithrombins Wibble and Wobble (T85M/K): Archetypal conformational diseases with in vivo latent - Transition, thrombosis, and heparin activation [J].
Beauchamp, NJ ;
Pike, RN ;
Daly, M ;
Butler, L ;
Makris, M ;
Dafforn, TR ;
Zhou, A ;
Fitton, HL ;
Preston, FE ;
Peake, IR ;
Carrell, RW .
BLOOD, 1998, 92 (08) :2696-2706
[2]   Mutant neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro [J].
Belorgey, D ;
Crowther, DC ;
Mahadeva, R ;
Lomas, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (19) :17367-17373
[3]   MOLECULAR EVOLUTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 FUNCTIONAL STABILITY [J].
BERKENPAS, MB ;
LAWRENCE, DA ;
GINSBURG, D .
EMBO JOURNAL, 1995, 14 (13) :2969-2977
[4]   Mapping of the epitope of a monoclonal antibody protecting plasminogen activator inhibitor-1 against inactivating agents [J].
Bodker, JS ;
Wind, T ;
Jensen, JK ;
Hansen, M ;
Pedersen, KE ;
Andreasen, PA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (08) :1672-1679
[5]   BIOLOGICAL IMPLICATIONS OF A 3-ANGSTROM STRUCTURE OF DIMERIC ANTITHROMBIN [J].
CARRELL, RW ;
STEIN, PE ;
WARDELL, MR ;
FERMI, G .
STRUCTURE, 1994, 2 (04) :257-270
[6]  
DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454
[7]   Biochemical properties of plasminogen activator inhibitor-1 [J].
Dupont, Daniel Miotto ;
Madsen, Jeppe Buur ;
Kristensen, Thomas ;
Bodker, Julie Stove ;
Blouse, Grant Ellsworth ;
Wind, Troels ;
Andreasen, Peter Andre .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 :1337-1361
[8]   Type-1 plasminogen-activator inhibitor - Conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility [J].
Egelund, R ;
Schousboe, SL ;
SottrupJensen, L ;
Rodenburg, KW ;
Andreasen, PA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 248 (03) :775-785
[9]   A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands - Ligand-induced serpin polymerization [J].
Egelund, R ;
Einholm, AP ;
Pedersen, KE ;
Nielsen, RW ;
Christensen, A ;
Deinum, J ;
Andreasen, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :13077-13086
[10]   TIME-RESOLVED POLARIZED FLUORESCENCE SPECTROSCOPY STUDIES OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 - CONFORMATIONAL-CHANGES OF THE REACTIVE CENTER UPON INTERACTIONS WITH TARGET PROTEASES, VITRONECTIN AND HEPARIN [J].
FA, M ;
KAROLIN, J ;
ALESHKOV, S ;
STRANDBERG, L ;
JOHANSSON, LBA ;
NY, T .
BIOCHEMISTRY, 1995, 34 (42) :13833-13840